AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.1 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Publishing Language: Chinese | Open Access

Liver sinusoidal endothelial cells: “accomplice” in chronic liver disease progression?

Wenshu HAN, Min SHEN ( ), Li QIAN ( )
School of Basic Medical Sciences & School of Public Health, Faculty of Medicine, Key Laboratory of the Jiangsu Higher Education Institutions for Nucleic Acid & Cell Fate Regulation, NATCM Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer, Yangzhou University, Yangzhou 225009, China
Show Author Information

Abstract

Liver sinusoidal endothelial cells (LSEC) are liver-specific endothelial cells. Under physiological conditions, LSECs exhibit open fenestrae, facilitating the efficient bidirectional exchange of small molecules between hepatocytes and blood. They are crucial for maintaining hepatic filtration and metabolic homeostasis, suppressing the activation of hepatic stellate cells (HSC), and modulating hepatic immune responses and tolerance, thereby forming the principal barrier of the liver microcirculation. During liver injury, however, LSECs undergo phenotypic changes—including capillarization, cellular senescence, and endothelial-to-mesenchymal transition. These changes result in increased intrahepatic vascular resistance, impaired transvascular exchange, and enhanced secretion of pro-angiogenic and pro-inflammatory factors. In the absence of timely intervention, this pathological cascade can exacerbate liver damage. Therefore, therapeutic targeting of LSEC dysfunction has emerged as a novel strategy for chronic liver disease. This article systematically elaborates on the dynamic changes and specific mechanistic roles of LSECs in both physiological homeostasis and chronic liver disease, summarizes current therapeutic strategies aimed at LSECs, and also discusses existing research limitations and suggests future directions.

CLC number: R575 Document code: A Article ID: 1007-4368(2026)06-809-11

References

【1】
【1】
 
 
Journal of Nanjing Medical University (Natural Sciences)
Pages 809-819

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
HAN W, SHEN M, QIAN L. Liver sinusoidal endothelial cells: “accomplice” in chronic liver disease progression?. Journal of Nanjing Medical University (Natural Sciences), 2026, 46(6): 809-819. https://doi.org/10.7655/NYDXBNSN250962

2

Views

0

Downloads

0

Crossref

Received: 31 August 2025
Revised: 24 December 2025
Accepted: 31 December 2025
Published: 15 June 2026
© 2026 Editorial Board of Journal of Nanjing Medical University(Natural Sciences)

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).